Published in Neuroreport on August 24, 1998
The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol Biol Cell (2002) 2.25
Here come the septins: novel polymers that coordinate intracellular functions and organization. J Cell Sci (2006) 1.60
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci U S A (1999) 1.60
Evidence for functional differentiation among Drosophila septins in cytokinesis and cellularization. Mol Biol Cell (2000) 1.51
A prototypic platelet septin and its participation in secretion. Proc Natl Acad Sci U S A (2002) 1.36
The septin CDCrel-1 is dispensable for normal development and neurotransmitter release. Mol Cell Biol (2002) 1.19
Septin 11 is present in GABAergic synapses and plays a functional role in the cytoarchitecture of neurons and GABAergic synaptic connectivity. J Biol Chem (2009) 1.02
Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum Mol Genet (2009) 1.01
Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci U S A (2003) 1.00
Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain. Hum Mol Genet (2012) 0.88
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi. J Neuropathol Exp Neurol (2010) 0.81
Mouse Models of 22q11.2-Associated Autism Spectrum Disorder. Autism Open Access (2012) 0.79
Localization of septin proteins in the mouse cochlea. Hear Res (2012) 0.75
Interaction of Recombinant Gallus gallus SEPT5 and Brain Proteins of H5N1-Avian Influenza Virus-Infected Chickens. Proteomes (2017) 0.75
Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science (2000) 4.42
The role of Myo2, a yeast class V myosin, in vesicular transport. J Cell Biol (1995) 4.11
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 2.71
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol (1994) 2.54
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat Neurosci (1999) 2.32
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet (1999) 1.96
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Evidence for anticipation in schizophrenia. Am J Hum Genet (1994) 1.85
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80
Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry (2003) 1.79
The potential impact of genetic counseling for mental illness. Clin Genet (2005) 1.77
Dementia as a complication of schizophrenia. J Neurol Neurosurg Psychiatry (2001) 1.77
Positive and negative symptoms in families with schizophrenia. Schizophr Res (1993) 1.74
Altered bowel habit and menstruation. Lancet (1976) 1.73
Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71
Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69
Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67
Kinetics and temperature dependence of exposure of endocytosed material to proteolytic enzymes and low pH: evidence for a maturation model for the formation of lysosomes. J Cell Physiol (1987) 1.63
Mortality in Crohn's disease. Q J Med (1980) 1.62
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57
pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
[Not Available]. BioDrugs (1997) 1.56
Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Complications of carbenoxolone therapy. Br Med J (1974) 1.54
The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51
Schizencephaly associated with psychosis. J Neurol Neurosurg Psychiatry (1997) 1.50
Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46
Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41
Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41
Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40
Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40
Reproductive fitness in familial schizophrenia. Schizophr Res (1996) 1.40
Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40
Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40
Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Etiology of gastric ulcer. Gastroenterology (1972) 1.37
Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36
Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36
'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33
Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study. Am J Psychiatry (2000) 1.30
Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29
Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29
Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet (1997) 1.29
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol (2000) 1.28
Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods. Pediatr Cardiol (2000) 1.28
Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis. J Pharm Pharmacol (1983) 1.22
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Br Med J (Clin Res Ed) (1983) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br J Clin Pharmacol (1984) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Coarse mucosal folds in the duodenum. Q J Med (1968) 1.18
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res (2003) 1.17
Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur J Immunol (1986) 1.17
SEC6 encodes an 85 kDa soluble protein required for exocytosis in yeast. Yeast (1992) 1.16
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry (2001) 1.13
Effect of ulcerative colitis and smoking on rectal blood flow. Gut (1990) 1.13
Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci (1981) 1.13
Fungal endophthalmitis following intraocular lens implantation. Am J Ophthalmol (1977) 1.12
A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer. Gut (1970) 1.12
Immunoglobulin E in rectal mucosa of patients with proctitis. Lancet (1975) 1.11
Diurnal variation in the quantitative EEG in healthy adult volunteers. Br J Clin Pharmacol (2000) 1.11
Increased reflux of bile into the stomach in gastric ulcer. Gut (1968) 1.10
Receptor for monomeric IgM on guinea-pig splenic macrophages. Nature (1973) 1.10
Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694. Br J Clin Pharmacol (1981) 1.10
SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex (1998) 1.08
Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology (2003) 1.08
Angina-like esophageal pain: differentiation from cardiac pain by history. J Clin Gastroenterol (1985) 1.07